Kraig Biocraft Laboratories Inc (KBLB) Annual Balance Sheets

Annual · GAAP · USD millions
Access KBLB quarterly Balance Sheets →
A period-by-period view of the balance sheet from Kraig Biocraft Laboratories Inc to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1.79
Security Deposit0.01
Deposits Assets, Current AS0.00
Cash & Short-term Investments1.00
Inventories0.03
Prepaid Expense, Current AS0.05
Total Current Assets1.88
Equipment/Property/Plant Net0.03
Long-term investments0.49
Other Assets, Noncurrent0.66
Total Assets2.57
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.51
Accrued Royalties, Current0.07
Notes Payable, Current NO1.49
Other Liabilities, Current8.38
Total Current Liabilities10.45
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.12
Operating Lease Liability Current0.05
Total Liabilities10.56
Stockholders' Equity
Common Stock Value31.02
Additional Paid In Capital Common Stock12.43
Retained Earnings / Accumulated Deficit-56.71
Other Equity5.26
Common Stockholder's Equity-8.00
Total Stockholder's Equity-8.00
Liabilities & Stockholder's Equity2.57
4 historic quarters locked

Sign in to unlock the full Kraig Biocraft Laboratories Inc balance sheet history.

About Kraig Biocraft Laboratories Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 30, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013630

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License